-
Needham & Company LLC Reaffirms "Buy" Rating for NewAmsterdam Pharma (NASDAQ:NAMS)
ソース: Buzz FX / 07 11 2024 09:26:16 America/New_York
Needham & Company LLC Reaffirms "Buy" Rating for NewAmsterdam Pharma (NASDAQ:NAMS) Written by MarketBeat November 7, 2024 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) 's stock had its "buy" rating re
Read more...